The 2020 COVID-19 pandemic has made a permanent mark on the healthcare industry. Many changes have taken place, new regulations and requirements are set for future implementation, and patients are now expecting a new standard of...
BioCareSD, a specialty distributor of life-saving therapies, today announced the addition of VIBATIV® and ULTOMIRIS® to its already extensive portfolio of life-saving therapies. With an ongoing commitment to broadening its product portfolio, BioCareSD is dedicated to...
The United States Food and Drug Administration (FDA) estimates that more than 30 million people living in the U.S. are affected by over 7,000 rare diseases. Many of these rare diseases do not...
Supply chain professionals must consider immediate impacts and contemplate possible implications for materials. As always, in developing internal supply chains, evaluating vendors and supplies, contingency planning, and communication will be critical. This major challenge highlights the need for...
Cold supply chains are necessary to ensure the efficacy of certain medications, vaccines and other biopharmaceutical products, but the addition of extreme temperatures presents new obstacles that can make the process even more difficult to manage...
When temperature-controlled supply chain operations fail, patients experience delays in receiving important medications. Tom Hart, COO of BioCare, provides insight into some challenges related to cold supply chain maintenance and emphasizes keeping the well-being of individual...
Your success as a pharmaceutical company heavily relies on the implementation of a quality management system. With ever-changing FDA regulations and technological advancements, the demand for solid infrastructure with quality in mind is increasing. Truthfully, the...
The U.S. Food and Drug Administration (FDA) recently announced the proposed rule, which aims to create a uniform national licensing standard for wholesale distributors and third-party logistics providers (3PLs). Historically, states have set...
There are a variety of challenges that patients may face when accessing medication. In fact, a 2019 study on medication access identified 17 distinct barriers that patients must overcome, including costs, transportation, and...
With deep knowledge and expertise, delivering critically needed and life-saving therapies to patients with rare, ultra-rare, and orphan diseases is our next guest’s passion and mission in life. Jeff Beck, Chief Development Officer at Biocare, joins us...
